Mergers & Acquisitions | featured news

Express Scripts Is Said to Be Near a Deal for WellPoint’s Pharmacy Unit

The deal could still collapse, people briefed on the talks said, but if it goes through it would be valued at nearly $5 billion.

 

Coke Isn't It For China

Beijing's rejection of the soft drink deal is a sign of rising nationalism.

 

Cisco To Buy Flip Camera Maker For $590 Million

Cisco To Buy Flip Camera Maker For $590 Million

After several days of behind-the-scenes negotiating, Cisco (NSDQ: CSCO) said it will acquire Pure Digital Technologies and its easy-to-use Flip Video camera for $590 million in stock. The deal also calls for Jonathan Kaplan, chairman and CEO of Pure Digital, to become general manager of Cisco's consumer business group.

 

I.B.M. Said to Be in Talks to Buy Sun for $7 Billion

I.B.M. Said to Be in Talks to Buy Sun for $7 Billion

The merger, if completed, would mark a big consolidation step in the market for server computers used in corporate data centers, one that could prompt an antitrust challenge.

 

Genentech, Roche Deal Hits Snag

Deal talks between Genentech and Roche hit a snag over dueling interpretations of arcane SEC rules, but the problem is unlikely to derail the transaction, according to people familiar with the matter.

 

Dow and Rohm Agree to Complete Merger

Dow Chemical and Rohm & Haas have reached a tentative deal to complete their disputed $15 billion merger, according to people briefed on the situation.

 

Merck to buy Schering-Plough in $41.1 billion deal

Merck to buy Schering-Plough in $41.1 billion deal

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

 

Roche Raises Bid for Genentech

Roche Raises Bid for Genentech

Swiss drug company Roche Holding increased its offer to acquire the rest of Genentech to $93 a share from $86.50.

 

Pfizer to buy Wyeth for $68B, cut 8000 jobs

Pfizer also said it would cut more than 8000 jobs to cut costs in anticipation of cholesterol drug Lipitor losing patent protection in 2011.

 

Chrysler, Fiat Hook Up

Chrysler, Fiat Hook Up

The struggling American auto maker Chrysler, owned by the private equity firm Cerberus Capital Management, signed an agreement with Fiat on Tuesday that would give the Italian car maker a 35% stake in the company.

 

Subscribe to this RSS topic: Syndicate content